本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Skye Bioscience Inc.

1.44
-0.1450-9.18%
盤後1.43-0.0048-0.33%19:49 EDT
成交量:58.76萬
成交額:88.06萬
市值:4,444.85萬
市盈率:-1.97
高:1.65
開:1.58
低:1.41
收:1.58
資料載入中...
2025/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/20

重要事件披露

Form 8-K - Current report
2025/02/26

重要事件披露

Form 8-K - Current report
2024/12/24

SEC問詢函

Form CORRESP - Correspondence
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/29

重要事件披露

Form 8-K - Current report
2024/10/24

重要事件披露

Form 8-K - Current report
2024/09/04

重要事件披露

Form 8-K - Current report
2024/08/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/03

重要事件披露

Form 8-K - Current report